increased heart rate with glp 1 Retatrutide rate: what the clinical data actually shows Does GLP-1 Increase Resting Heart
Description
My clients have started to report this very thing
As a result, clinicians are exploring whether these drugs can complement insulin therapy rather than replace it
Youssef, M
doi: 10.1016/j.atherosclerosis.2018.07.016
The GLP-1 receptor agonist market is still primarily anchored in type 2 diabetes management, where these drugs improve glycemic control, reduce HbA1c levels, and mitigate cardiovascular risks
p = 0.0044), a 4.5% absolute reduction in UTIs, and a better 1-year UTI-free survival (log-rank p = 0.0420) (Table 2)
